Amdocs (NASDAQ:DOX) Stock: Insider La Vega Rafael De Purchases 2,297 Shares

Key Points

  • Director La Vega Rafael De bought 2,297 shares at an average price of $44.51, a purchase worth about $102,239 that increased his holdings by 6.4%.
  • Amdocs matched quarterly estimates with EPS of $1.98 and revenue of $1.19 billion; revenue rose 3.8% year over year. The company announced a quarterly dividend of $0.569 per share, equivalent to a 5.2% annualized yield.
  • Analyst views were mixed, with a consensus “Hold” rating and an average price target of $69. The article also reported shares opened at $43.64, well below their 50-day and 200-day moving averages.

Amdocs Limited (NASDAQ:DOX - Get Free Report) Director La Vega Rafael De purchased 2,297 shares of the stock in a transaction on Thursday, November 12th. The shares were purchased at an average price of $44.51 per share, with a total value of $102,239.47. Following the acquisition, the director owned 38,191 shares in the company, valued at approximately $1,699,881.41. The trade was a 6.40% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Amdocs Stock Down 2.6%

Shares of NASDAQ DOX opened at $43.64 on Tuesday. The company's 50 day moving average price is $57.14 and its 200-day moving average price is $60.79. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.94 and a current ratio of 0.94. Amdocs Limited has a 52-week low of $39.96 and a 52-week high of $84.95. The company has a market capitalization of $4.71 billion, a P/E ratio of 6.65, a price-to-earnings-growth ratio of 1.44 and a beta of 0.42.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, hitting the consensus estimate of $1.98. Amdocs had a net margin of 10.59% and a return on equity of 20.81%. The company had revenue of $1.19 billion during the quarter, compared to analysts' expectations of $1.19 billion. During the same period in the prior year, the company posted $1.83 earnings per share. Amdocs's revenue for the quarter was up 3.8% compared to the same quarter last year. Equities analysts forecast that Amdocs Limited will post 5.82 earnings per share for the current year.

Amdocs Dividend Announcement




The company also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be issued a $0.5690 dividend. The ex-dividend date is Thursday, December 31st. This represents a $2.28 annualized dividend and a yield of 5.2%. Amdocs's payout ratio is presently 48.82%.

Analyst Ratings Changes

A number of analysts have weighed in on DOX shares. Oppenheimer downgraded Amdocs from an "outperform" rating to a "market perform" rating in a report on Wednesday, November 4th. Zacks Research lowered Amdocs from a "hold" rating to a "strong sell" rating in a research report on Monday, November 9th. Weiss Ratings raised Amdocs from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Friday, October 23rd. Stifel Nicolaus cut their target price on Amdocs from $71.00 to $46.00 and set a "buy" rating on the stock in a research report on Wednesday, November 4th. Finally, Wall Street Zen cut Amdocs from a "buy" rating to a "hold" rating in a research note on Saturday, November 7th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $69.00.

Read Our Latest Analysis on DOX

Institutional Trading of Amdocs

Several hedge funds have recently modified their holdings of DOX. Pzena Investment Management LLC lifted its position in shares of Amdocs by 3.4% during the 3rd quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company's stock valued at $826,532,000 after acquiring an additional 469,581 shares during the period. Dimensional Fund Advisors LP boosted its stake in Amdocs by 19.7% during the first quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company's stock worth $226,045,000 after acquiring an additional 571,036 shares in the last quarter. First Trust Advisors LP boosted its stake in Amdocs by 18.7% during the third quarter. First Trust Advisors LP now owns 1,637,842 shares of the technology company's stock worth $93,652,000 after acquiring an additional 258,098 shares in the last quarter. Bank of America Corp DE grew its holdings in Amdocs by 29.1% in the first quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company's stock worth $82,375,000 after purchasing an additional 284,435 shares during the period. Finally, Russell Investments Group Ltd. grew its holdings in Amdocs by 11.2% in the third quarter. Russell Investments Group Ltd. now owns 1,112,976 shares of the technology company's stock worth $63,703,000 after purchasing an additional 111,800 shares during the period. Institutional investors own 92.02% of the company's stock.

About Amdocs

(Get Free Report)

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Amdocs?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Amdocs and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles